ObamaCare changes have different influence on diverse healthcare business. Pharmaceutical industry seems to gain on this reform unlike the insurance business. In this article we briefly present the main positive and negative effects of health reform in the US. Then, we point to the impact of ObamaCare on profits, costs and activities of pharmaceutical companies. We discuss changes such as: increase in sales of prescription drugs; new rules of registration of generic drugs; novel tax on sales of original drugs; incentives for pharma to put more attention to specific fields in R&D; bigger transparency in relations between physicians and pharma industry.
The characteristics of medical and sanitary practice and its development during the inter-war period (1919–1939), the role of the state in the fight against infectious and social diseases, the characteristics and the evaluation of the activity of the newly organised Epidemic Hospitals, Health Centres, Hospital Sick-Funds and other institutions providing anti-epidemic measures and health care protection are presented using the example of one area in the eastern provinces of the Second Rzeczpospolita.
PL
Artykuł na przykładzie konkretnego regionu województw wschodnich Drugiej Rzeczypospolitej charakteryzuje rozwój i stan opieki medyczno-sanitarnej w dwudziestoleciu międzywojennym (lata 1919–1939), pokazuje rolę państwa w zwalczaniu chorób zakaźnych i społecznych, opisuje i ocenia działalność nowo powstałych szpitali epidemicznych, ośrodków zdrowia, kas chorych i innych form i ich rolę w zapewnieniu ochrony epidemiologicznej oraz zdrowia obywateli.
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.